Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test the safety of placing Deep Brain Stimulators (DBS) in a part of the brain called the cerebellum and using electrical stimulation of that part of the brain to treat movement symptoms related to cerebral palsy. Ten children and young adults with dyskinetic cerebral palsy will be implanted with a Medtronic Percept Primary Cell Neurostimulator. We will pilot videotaped automated movement recognition techniques and formal gait analysis, as well as collect and characterize each subject's physiological and neuroimaging markers that may predict hyperkinetic pathological states and their response to therapeutic DBS.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06122675
Study type Interventional
Source University of California, San Francisco
Contact Marta San Luciano Palenzuela, MD, MS
Phone 4153532311
Email Marta.SanLucianoPalenzuela@ucsf.edu
Status Recruiting
Phase Phase 1/Phase 2
Start date July 1, 2024
Completion date July 1, 2029

See also
  Status Clinical Trial Phase
Recruiting NCT01361373 - Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study Phase 4
Not yet recruiting NCT05612464 - Enhancing Sensorimotor Processing in Children With Dystonia